Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...
The CDMO market is poised for growth due to rising R&D spending, increased demand for generics and biologics, patent ...
DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...
Biopharma is embracing digital twins in a big way, with a growing number of companies using computational models to streamline and optimize more parts of the drug discovery, testing, and manufacturing ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E.
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already ...
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.
ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results